Table 3 Tumor characteristics associated with 30-day postoperative morbidity
Characteristics (Number of patients; N = 102) | Number of patients with intra-operative morbidity (%) | Odd’s ratio | p-value |
|---|---|---|---|
Liver metastasis | 0.207 | ||
 No (90) | 35 (38.9) | – |  |
 Yes (12) | 7 (58.3) | 2.200 (0.647–7.477) |  |
Lung metastasis | 0.716 | ||
 No (98) | 40 (40.8) | – |  |
 Yes (4) | 2 (50.0) | 1.450 (0.196–10.724) |  |
Bone metastasis | 0.060 | ||
 No (101) | 41 (40.6) | – |  |
 Yes (1) | 1 (100.0) | 1.000 (0.459–1.016) |  |
Peritoneal seedlings | 0.215 | ||
 No (94) | 37 (39.4) | – |  |
 Yes (8) | 5 (62.5) | 2.567 (0.578–11.392) |  |
Ascites present | 0.925 | ||
 No (95) | 39 (41.1) |  |  |
 Yes (7) | 3 (42.9) | 1.076 (0.228–5.082) |  |
Pelvic attachment | 0.208 | ||
 No (77) | 29 (37.7) | – |  |
 Yes (25) | 13 (52.0) | 1.793 (0.721–4.454) |  |
Stage of disease | 0.613 | ||
 Stage 1 (6) | 4 (66.7) | – |  |
 Stage 2 (10) | 4 (40.0) | 0.333 (0.040–2.768) |  |
 Stage 3 (59) | 18 (30.5) | 0.219 (0.036–1.308) |  |
 Stage 4 (27) | 16 (59.3) | 0.727 (0.112–4.685) |  |
Neoadjuvant chemoradiation | 0.340 | ||
 No (33) | 16 (48.5) | – |  |
 Yes, a short course (21) | 8 (38.1) | 0.653 (0.214–1.992) |  |
 Yes, a long course (48) | 18 (37.5) | 0.637 (0.259–1.565) |  |
Surgical procedure | 0.019** | ||
 ISR only (92) | 34 (36.9) | – |  |
 ISR + extended organ resection (10) | 8 (80.0) | 6.823 (1.369–34.009) |  |